AXIS CAPITAL HOLDINGS LIMITED
In the published model solve dated 2026-Q2, anchored at $99.52, AXIS CAPITAL HOLDINGS LIMITED (AXS) is priced for 10.0% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• The price assumes this insurer settles at a return on equity of roughly 11.2%, while it has recently been earning about 16.9%, and almost every argument about the stock is really an argument about which of those two figures describes the next decade. • The rate cycle has turned, and the company says so in its own words: ⟦overall pricing has moderated and in some sectors is softening. Casualty lines continue to see positive rate achievement while property rates are deteriorating⟧. • Second-quar
Is AXS overvalued? See what's priced in →
451 institutional managers reported holding AXS in 13F filings for the quarter ended 2026-03-31. Together they hold about 93% of the company; the top 10 hold 40%. 40 opened new positions that quarter. Held by Vanguard Group, AQR Capital, Dimensional Fund Advisors, among others. On the short side, 2.0M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (3.2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
AXS has cut its share count 12.6% over the past five years, spending $1.18B on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting); the current rate is $1.76 a share annually. Cash returned over the past three years: $405.39M in dividends and $1.15B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at AXS over the trailing three years: 2024: 4 buys totaling $854k. 18 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
AXS's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-02 | +2.2% | -0.8% |
| 2023-11-03 | -5.4% | +3.4% |
| 2024-02-28 | +0.6% | -1.1% |
| 2024-05-02 | +6.3% | +6.5% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
AXS's latest 8-K filings: 2026-07-28 (items 2.02, 9.01); 2026-06-15 (items 5.02, 7.01, 9.01); 2026-05-18 (items 5.07); 2026-04-29 (items 2.02, 9.01); 2026-03-26 (items 5.02).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.